Document is current
Any future updates will be listed below
-
Authors
Wen, Wei
Quan, Zi-Jun
Li, Si-Ang
Yang, Zhi-Xue
Fu, Ya-Wen
Zhang, Feng
Li, Guo-Hua
Zhao, Mei
Yin, Meng-Di
Xu, Jing
Zhang, Jian-Ping
Cheng, Tao
Zhang, Xiao-Bing
-
Funding
Funding for this research was provided by:
Ministry of Science and Technology of the People's Republic of China (2016YFA0100600, 2019YFA0110800, 2019YFA0110204)
National Natural Science Foundation of China (81421002, 81890990, 81730006, 81570164, 81770198, 81870149, 81700183, 81700184)
CAMS Initiative for Innovative Medicine (2017-I2M-2-001, 2019-I2M-1-006, 2016-I2M-1-017, 2017-I2M-B&R-04)
CAMS Fundamental Research Funds for Central Research Institutes (2018PT31004)
- License Information
-
More Information
Article History
Received: 16 November 2020
Accepted: 6 August 2021
First Online: 20 August 2021
Declarations
:
: Peripheral blood mononuclear cells (PBMCs) were isolated from healthy donors’ PB from Tianjin blood center (China) with approval of the local research ethics committee (approval number: KT2020059-EC-1). Cord blood samples were procured from VCANBIO life bank (Nation Industrial Base Cell Technology) upon the approval of the local research ethics committee (approval number: KT2020084-EC-1). Human induced pluripotent stem cells were made in the house previously. The experimental methods in this study comply with the Helsinki Declaration.
: Not applicable.
: The authors declare that they have no competing interests.
